Common mutations in genes such as BRAF, TP53, and KRAS/NRAS are correlated strongly with increased pathogenesis within these cancer groups, but it is not known what genetic signatures may be responsible for distinguishing these differing classes of undifferentiated cancers within each site [17,18,19]. This evidence concerns the gene KRAS and cancer.